83North

Ibex Medical Analytics Ltd, based in Tel Aviv, Israel, specializes in developing AI-based diagnostic systems for cancer pathology. The company's flagship product, the Ibex Second Read system, works alongside human pathologists to analyze cases, identifying discrepancies in diagnoses. This innovative technology harnesses artificial intelligence, data science, and machine learning to analyze digitized glass slides and electronic medical records, revealing critical patterns that enhance clinical decision-making. By streamlining pathology workflows, Ibex aims to provide rapid, objective, and accurate diagnoses, ultimately improving patient outcomes and quality of life. The company comprises a multidisciplinary team of entrepreneurs, data scientists, software engineers, and medical experts dedicated to advancing cancer care through AI applications in diagnostics.

Foretellix Ltd. is a company based in Tel Aviv, Israel, focused on developing a verification framework for Intelligent Autonomous Systems, particularly in the realm of Autonomous Vehicles. Founded in 2010, Foretellix offers solutions that automate the safety verification of complex automated driving systems, addressing the challenges of risk, cost, and time to market. The company has created a platform that automates the analysis of safety-related coverage metrics, ensuring that vehicles perform correctly across a wide range of driving scenarios. This platform enables comprehensive coverage verification services, which are essential for confirming the safety and reliability of autonomous vehicles prior to their deployment. Additionally, Foretellix has developed a standardized language for describing autonomous vehicle scenarios, further enhancing its contributions to the field of automotive safety verification.

Opsys Tech is a fast-growing private company providing solutions for a wide range of applications utilizing fiber optics technologies. It is a spinoff of a worldwide leading optical communication company Finsar Corporation. In addition to OPSYS existing product line in the optical communication market, OPSYS is also involved in the development of products and technologies for new applications in the optical market such as Autonomous vehicle control and intelligent sensors. Opsys Technologies develops a multiwavelength solid-state lidar product for use in autonomous vehicles.

Ibex Medical Analytics Ltd, based in Tel Aviv, Israel, specializes in developing AI-based diagnostic systems for cancer pathology. The company's flagship product, the Ibex Second Read system, works alongside human pathologists to analyze cases, identifying discrepancies in diagnoses. This innovative technology harnesses artificial intelligence, data science, and machine learning to analyze digitized glass slides and electronic medical records, revealing critical patterns that enhance clinical decision-making. By streamlining pathology workflows, Ibex aims to provide rapid, objective, and accurate diagnoses, ultimately improving patient outcomes and quality of life. The company comprises a multidisciplinary team of entrepreneurs, data scientists, software engineers, and medical experts dedicated to advancing cancer care through AI applications in diagnostics.

Five Sigma LTD. is a software company based in Tel Aviv-Yafo, Israel, that specializes in automating the claims management process for the insurance industry through its cloud-based platform. Founded in 2017, Five Sigma offers a data-driven Claims Management Solution that incorporates artificial intelligence and machine learning capabilities. This platform streamlines claims processing by implementing automated workflows and utilizing data modeling to provide insightful recommendations, enhancing decision-making for insurance adjusters and minimizing errors. The solution is utilized by various entities within the insurance sector, including leading insurance carriers, Insurtech firms, third-party administrators, and self-insured organizations, to modernize their claims operations, reduce claims leakage, ensure compliance, and enhance overall customer experience.

Foretellix Ltd. is a company based in Tel Aviv, Israel, focused on developing a verification framework for Intelligent Autonomous Systems, particularly in the realm of Autonomous Vehicles. Founded in 2010, Foretellix offers solutions that automate the safety verification of complex automated driving systems, addressing the challenges of risk, cost, and time to market. The company has created a platform that automates the analysis of safety-related coverage metrics, ensuring that vehicles perform correctly across a wide range of driving scenarios. This platform enables comprehensive coverage verification services, which are essential for confirming the safety and reliability of autonomous vehicles prior to their deployment. Additionally, Foretellix has developed a standardized language for describing autonomous vehicle scenarios, further enhancing its contributions to the field of automotive safety verification.

Ibex Medical Analytics Ltd, based in Tel Aviv, Israel, specializes in developing AI-based diagnostic systems for cancer pathology. The company's flagship product, the Ibex Second Read system, works alongside human pathologists to analyze cases, identifying discrepancies in diagnoses. This innovative technology harnesses artificial intelligence, data science, and machine learning to analyze digitized glass slides and electronic medical records, revealing critical patterns that enhance clinical decision-making. By streamlining pathology workflows, Ibex aims to provide rapid, objective, and accurate diagnoses, ultimately improving patient outcomes and quality of life. The company comprises a multidisciplinary team of entrepreneurs, data scientists, software engineers, and medical experts dedicated to advancing cancer care through AI applications in diagnostics.

Foretellix Ltd. is a company based in Tel Aviv, Israel, focused on developing a verification framework for Intelligent Autonomous Systems, particularly in the realm of Autonomous Vehicles. Founded in 2010, Foretellix offers solutions that automate the safety verification of complex automated driving systems, addressing the challenges of risk, cost, and time to market. The company has created a platform that automates the analysis of safety-related coverage metrics, ensuring that vehicles perform correctly across a wide range of driving scenarios. This platform enables comprehensive coverage verification services, which are essential for confirming the safety and reliability of autonomous vehicles prior to their deployment. Additionally, Foretellix has developed a standardized language for describing autonomous vehicle scenarios, further enhancing its contributions to the field of automotive safety verification.